- Home
- ESPR vs ASPN Comparison
ESPR vs ASPN Comparison
Compare ESPR & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- ASPN
- Stock Information
- Founded
- ESPR 2008
- ASPN 2001
- Country
- ESPR United States
- ASPN United States
- Employees
- ESPR N/A
- ASPN N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- ESPR Health Care
- ASPN Consumer Discretionary
- Exchange
- ESPR Nasdaq
- ASPN Nasdaq
- Market Cap
- ESPR 534.3M
- ASPN 573.2M
- IPO Year
- ESPR 2013
- ASPN 2014
- Fundamental
- Price
- ESPR $2.55
- ASPN $8.37
- Analyst Decision
- ESPR Buy
- ASPN Strong Buy
- Analyst Count
- ESPR 6
- ASPN 8
- Target Price
- ESPR $6.50
- ASPN $19.29
- AVG Volume (30 Days)
- ESPR 7.0M
- ASPN 1.7M
- Earning Date
- ESPR 11-06-2025
- ASPN 11-05-2025
- Dividend Yield
- ESPR N/A
- ASPN N/A
- EPS Growth
- ESPR N/A
- ASPN N/A
- EPS
- ESPR N/A
- ASPN N/A
- Revenue
- ESPR $268,125,000.00
- ASPN $397,175,000.00
- Revenue This Year
- ESPR $13.05
- ASPN N/A
- Revenue Next Year
- ESPR N/A
- ASPN $8.56
- P/E Ratio
- ESPR N/A
- ASPN N/A
- Revenue Growth
- ESPR N/A
- ASPN 11.18
- 52 Week Low
- ESPR $0.69
- ASPN $4.16
- 52 Week High
- ESPR $3.94
- ASPN $26.90
- Technical
- Relative Strength Index (RSI)
- ESPR 47.71
- ASPN 61.46
- Support Level
- ESPR $2.35
- ASPN $7.88
- Resistance Level
- ESPR $3.41
- ASPN $9.03
- Average True Range (ATR)
- ESPR 0.18
- ASPN 0.44
- MACD
- ESPR -0.03
- ASPN 0.15
- Stochastic Oscillator
- ESPR 9.79
- ASPN 61.52
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.